Concordia International (TSE:CXR) (NASDAQ:CXRX) Director John Beighton sold 147,000 shares of the company’s stock in a transaction on Thursday, March 22nd. The stock was sold at an average price of C$0.68, for a total transaction of C$99,960.00.
John Beighton also recently made the following trade(s):
- On Monday, March 19th, John Beighton sold 34,000 shares of Concordia International stock. The stock was sold at an average price of C$0.75, for a total transaction of C$25,500.00.
Shares of Concordia International stock traded down C$0.02 during trading hours on Thursday, reaching C$0.63. 61,876 shares of the company’s stock were exchanged, compared to its average volume of 112,727. Concordia International has a 1 year low of C$0.58 and a 1 year high of C$2.88.
About Concordia International
Concordia International Corp., a specialty pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products. The company operates through two segments, Concordia International and Concordia North America. The Concordia International segment owns or licenses a portfolio of branded and generic prescription products to wholesalers, hospitals, and pharmacies.
Receive News & Ratings for Concordia International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concordia International and related companies with MarketBeat.com's FREE daily email newsletter.